Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC clinical trial (NCT06405490). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC clinical trial (NCT06405490). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC clinical trial (NCT06405490). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my participation involve in terms of visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC clinical trial (NCT06405490). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC clinical trial (NCT06405490). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC clinical trial (NCT06405490). Contact the study team or your healthcare provider for specific answers.

What this study is about